USDT Issuer Tether May Pursue Mega Raise As SEC Considers On-Chain Stocks, JPMorgan and DePIN Moves Highlight TradFi Shift

Tether funding round talks signal major institutional interest in stablecoin infrastructure, with reported investors like SoftBank and ARK exploring a potential $20B raise that could value Tether near $500B. This move highlights TradFi’s push into crypto infrastructure and tokenization. — COINOTAG Tether funding round reportedly could value issuer near $500B, attracting top venture ￰0￱ explores allowing US stocks to trade onchain via regulated digital-asset platforms. JPMorgan’s Kinexys now serves a major Qatari bank; Predictive Oncology builds a $344.4M DePIN token ￰1￱ funding round draws TradFi into crypto infrastructure; read the latest on SEC onchain stocks, Kinexys adoption, and a DePIN ￰2￱ for ￰3￱ dives deeper into crypto: Tether’s mega raise, SEC eyes onchain stocks, JPMorgan expands Kinexys and a biotech bets treasury on ￰4￱ SoftBank and ARK eyeing investment in Tether’s mega funding round?

Tether funding round discussions reportedly involve high-profile investors evaluating a potential $20-billion raise that could value the stablecoin issuer near $500 ￰5￱ Ardoino confirmed outreach to a select group of investors but provided no structural ￰6￱ signals strong institutional interest in stablecoin infrastructure.) integrated JPMorgan’s Kinexys to speed corporate US-dollar payments and enable near-real-time ￰7￱ executives emphasized faster cross-border payments and round-the-clock capability, calling the platform a “treasurer’s dream.” Operational impact: Kinexys processes about $3 billion in daily transactions and promises sub-minute settlement for eligible flows, improving treasury efficiency and liquidity management for corporate ￰8￱ did Predictive Oncology form a DePIN-focused crypto treasury?

Predictive Oncology allocated a $344.4-million digital-asset treasury entirely to Aethir (ATH) tokens, partnering with Web3 advisors and an investment bank to structure the ￰9￱ marks a notable instance of a Nasdaq-listed company embracing DePIN exposure at ￰10￱ market cap.